Tighter Systolic BP Control Could Save 100K U.S. Lives Annually

Share this content:
Tighter Systolic BP Control Could Save 100K U.S. Lives Annually
Tighter Systolic BP Control Could Save 100K U.S. Lives Annually

FRIDAY, Sept. 16, 2016 (HealthDay News) -- Engaging Americans at high risk for cardiovascular disease in aggressive efforts to lower their systolic blood pressure could save more than 100,000 lives a year, according to a study presented at the American Heart Association's Council on Hypertension 2016 Scientific Sessions, held from Sept. 14 to 17 in Orlando, Fla.

Holly Kramer, M.D., M.P.H., an associate professor of public health sciences and medicine at Loyola Medical Center in Maywood, Ill., and colleagues utilized 1999 to 2006 health data from the Systolic Blood Pressure Intervention Trial (SPRINT) which was released in 2015. The SPRINT trial included adults age 50 years and older with SBP of 130 to 180 mm Hg, all with high cardiovascular disease risk.

Based on an annual death rate of 2.2 percent for that population, they predicted that approximately 107,000 deaths could be prevented each year through intensive systolic blood pressure lowering (to less than 120 mm Hg). Of the 18 million participants studied, 8.9 million had systolic readings at the higher end of the spectrum -- 145 mm Hg or greater. And their annual death rate was 2.5 percent. But with intensive control, researchers projected that 61,000 deaths would be avoided each year.

"The SPRINT clinical trial clearly showed that intensive systolic blood pressure lowering lowers risk of death from all causes and will save lives among adults aged 50 years and older," Kramer said in a news release from the American Heart Association.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »